CMT Capital Markets Trading’s Teva Pharmaceuticals TEVA Stock Holding History

CMT Capital Markets Trading’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$505K	Sell	14,912 -21,839	-59%	-$727K	﹤0.01%	337
2026 Q1	$1.11M	Buy	36,751 +2,151	+6%	+$69.2K	0.01%	271
2025 Q4	$1.08M	Sell	34,600 -29,089	-46%	-$717K	0.01%	276
2025 Q3	$1.29M	Sell	63,689 -4,370	-6%	-$76.8K	0.01%	260
2025 Q2	$1.14M	Sell	68,059 -9,385	-12%	-$151K	0.01%	235
2025 Q1	$1.19M	Buy	+77,444	New	+$1.38M	0.02%	217

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

CMT Capital Markets Trading's TEVA Position: Q2 2026 in Review

CMT Capital Markets Trading reduced its Teva Pharmaceuticals (TEVA) stake by 59% in Q2 2026, selling an estimated $727K and leaving 14,912 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #337.

CMT Capital Markets Trading first reported a position in TEVA in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.29M in Q3 2025. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

CMT Capital Markets Trading held 14,912 shares of Teva Pharmaceuticals worth $505K as of Q2 2026.
CMT Capital Markets Trading sold 21,839 Teva Pharmaceuticals shares in Q2 2026, an estimated $727K.
Teva Pharmaceuticals made up ﹤0.01% of CMT Capital Markets Trading's portfolio in Q2 2026, its #337 holding.
CMT Capital Markets Trading first reported a position in Teva Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
CMT Capital Markets Trading's Teva Pharmaceuticals position peaked at $1.29M in Q3 2025.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on CMT Capital Markets Trading's 13F filing for Q2 2026, filed 13 Aug 2026.